National Plan for the Prevention of Cardiovascular Diseases

Objectives

The strategy seeks to reduce the burden of cardiovascular disease through integrated prevention, early detection, treatment, surveillance, workforce development, public education and research. Its strategic emphasis is on addressing modifiable risks, improving access to quality services across all levels of care, and using national data systems to guide continuous assessment and improvement.[1][2][3][4]

• Increase public awareness of cardiovascular risk factors, healthy nutrition, physical activity and tobacco-related harms, including through annual campaigns, school educational materials and communication on smoking restrictions in enclosed places. The plan identifies targets of four awareness campaigns and four physical-activity campaigns annually.[1][5]
• Promote healthier environments and support legislation that reduces exposure to unhealthy food and tobacco smoke.[1]
• Establish early-detection programmes for people at high cardiovascular risk, with screening for hypertension, cholesterol and other relevant risk factors, and strengthen follow-up through registers or integrated monitoring systems.[6][4]
• Improve primary healthcare capacity through accredited cardiovascular education, continuing professional development, evidence-based standards, quality improvement and ongoing performance review.[6][5]
• Develop coordinated referral arrangements for cardiovascular diseases across the three care levels, supported by electronic patient records and a health-service network.[2]
• Build a comprehensive cardiovascular database, dedicated information system and standardised national patient-registration system to enable continuing assessment of service delivery and disease trends.[2]
• Conduct epidemiological research on disease burden, determinants, economic effects, services for high-risk groups and patients, and community satisfaction.[2]
• Strengthen the availability of prevention, diagnosis and treatment services, including specialised clinics, essential medicines, diagnostic testing, electrocardiography, consultant clinics and advanced cardiovascular centres in line with national need.[7][3]

Implementation

Implementation combines phased national planning, primary-care-led prevention and screening, hospital and specialist services, workforce training, public communication, electronic information systems and national clinical governance. Delivery is planned in five phases from 2010 to 2019, alongside approval of the national plan and establishment of a national committee; the supplied material does not specify the committee's membership, legal authority or detailed accountability arrangements.[7][8]

• Deliver prevention through public campaigns, school-based materials, nutrition and physical-activity initiatives, professional and patient associations, workshops, lectures, seminars, camps, print media and television programmes.[1][4]
• Operate healthy-person clinics in health centres through an appointment system, integrating cardiovascular-risk awareness and screening for hypertension, raised cholesterol and smoking.[6]
• Provide primary-care testing for blood pressure, glucose, lipids, renal function and relevant biochemical measures, with listed access to glucose-lowering, blood-pressure-lowering and lipid-lowering medicines, aspirin, antibiotics and rheumatic-fever prophylaxis.[7]
• Strengthen the workforce through accredited programmes, specialist workshops and annual training for doctors, nurses, nutritionists and other health-sector personnel.[6][5][3]
• Establish scientific committees to develop and update evidence-based clinical guidance for health workers and practitioners, while applying monitoring, review and quality-improvement mechanisms in primary healthcare and hospitals.[5][3]
• Maintain national registers for acute coronary syndrome, hypertension, cardiomyopathy, cardiovascular risk factors and diabetes, and use electronic reminders and paper records to support follow-up.[5][3]
• Assess implementation through a comprehensive database, cardiovascular information system and unified patient registry, supplemented by epidemiological studies at the beginning, midpoint and end of each implementation stage.[2]
• Measure community satisfaction every two years, with five survey rounds planned, and monitor service readiness through the availability of specialised clinics, medicines, diagnostic tests, equipment, consultant clinics and advanced centres.[2][7][3]
• Track population outcomes and risk factors using indicators including cardiovascular hospital admissions and mortality per 100,000 population, cardiovascular disease and undiagnosed-case prevalence, impaired glucose metabolism, raised blood pressure, raised cholesterol and triglycerides, obesity, overweight, physical activity, smoking, fruit and vegetable consumption, and metabolic syndrome.[8]
• Fund some physical-activity campaigns and electronic reminder and follow-up systems within the diabetes-control budget. The supplied extracts contain annual and ten-year budget-table references but no numerical allocations, total funding, currency, financing gaps or resource-mobilisation arrangements.[5][2][7]

Monitoring & Evaluation

Monitoring and evaluation combine phased implementation review, service-readiness assessment, population surveillance, patient registers, research, community feedback and quality-improvement mechanisms. The plan is structured across five phases from 2010–2011 to 2018–2019, with provision for national-plan approval and a national committee, although the extracts do not define that committee’s accountability role.[7][8]

• Assess awareness initiatives through field evaluation before and after implementation, using measurement indicators to identify change.[1]
• Monitor delivery of annual awareness and physical-activity campaigns against targets of four campaigns in each category per year.[1][5]
• Track early detection, referral and follow-up through cardiovascular registers or integrated monitoring systems, including use of healthy-person clinic appointments and electronic reminder systems.[6][5][2]
• Maintain a comprehensive database, a dedicated cardiovascular information system and a unified national patient-registration system to enable continuous assessment of implementation and disease trends.[2]
• Evaluate epidemiological patterns, determinants, economic impact and services through studies undertaken at the beginning, midpoint and end of each implementation stage.[2]
• Measure public experience through community-satisfaction surveys every two years, with five survey rounds planned.[2]
• Monitor service capacity through availability of specialised primary-care clinics, essential medicines, diagnostic tests and equipment, consultant clinics and advanced cardiovascular centres.[7][3]
• Maintain national registers for acute coronary syndrome, hypertension, cardiomyopathy, cardiovascular risk factors and diabetes to monitor disease and risk-factor patterns.[3]
• Review quality through scientific committees, evidence-based standards, continuing professional review, paper records, electronic follow-up and performance standards for specialist clinics.[5]

Population indicators include hospital admission and mortality rates per 100,000 population for specified cardiovascular causes; cardiovascular disease and undiagnosed-case prevalence; impaired glucose metabolism; raised blood pressure using the listed 130/80 threshold; elevated cholesterol above 5.2 mmol/L; raised triglycerides; obesity and overweight; physical activity; smoking; fruit and vegetable consumption; and metabolic syndrome prevalence. The relevant measures apply to people aged over 20 where specified in the indicator set.[8]

Additional prevention-related monitoring covers early detection of cardiovascular disease, blood-pressure and lipid screening, rheumatic-fever prevention and a planned national research study.[4]The extracts do not specify a consolidated reporting timetable, data-quality procedures, publication arrangements, independent evaluation process, or a clearly defined accountability mechanism.[1][6][5][8]

Costing & Financing

The source refers to annual and ten-year budget tables and identifies selected activities as financed within the diabetes-control budget, but the supplied extracts contain no numerical allocations, total costs or currency amounts.[1][6][5][2][7]

• Fund physical-activity campaigns within the diabetes-control budget.[5]
• Fund electronic reminder and follow-up systems within the diabetes-control budget.[5]
• Include annual total-value columns for activities, without providing the associated numerical values in the extracts.[1][6][5]
• Present ten-year and annual budget tables, without disclosing allocations or overall budget totals in the supplied material.[2][7]

No detailed allocation by intervention, funding source beyond the diabetes-control budget, funding gap, resource-mobilisation arrangement, expenditure schedule, economic assumption or cost-effectiveness analysis is specified in the supplied extracts.[1][6][5][2][7][8]